Publications

Search for Publications

List of Publications

Sort by: Date | Author | Title

Andersen, R., Jespersen, M. S., Presti, M., Bjornhart, B., Østby, A. C., Darras, A. K. M., Garitaonaindia, Y., Ruhlmann, C. H., Frank, M. S., Schmidt, H., Friis, R. B., Guldbrandt, L. M., Henriksen, J. R., Bjerrum, A., Simonsen, K. S., Palshof, J. A., Borch, T. H., Andersen, J. L., Kjaer, S. ... Donia, M. (2026). Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC. European Journal of Cancer, 243, Article 116872. https://doi.org/10.1016/j.ejca.2026.116872
Høgsbjerg, K. W., Thomsen, M. S., Maae, E., Mjaaland, I., Nielsen, M. H., Maraldo, M. V., Kirkove, C., Lörincz, T., Al-Rawi, S. A. J., Blix, E. S., Schreiber, A., Krause, M., Kasti, U. M., Matthiessen, L. W., Petersen, S. E., Overgaard, J. & Offersen, B. V. (2026). Validation of the ESTRO target volume consensus guideline for early-stage breast cancer in the DBCG Skagen Trial 1. Radiotherapy and Oncology, 221, Article 111594. https://doi.org/10.1016/j.radonc.2026.111594
Bhavsar, R., Tang, M., Thuesen, L., Kjaergaard-Andersen, G. & Jakobsen, C. J. (2026). Sex disparities in coronary re-vascularisation and mortality. BMC Cardiovascular Disorders, 26(1), Article 494. https://doi.org/10.1186/s12872-026-05688-x
Peck-Radosavljevic, M., Abdelgafur, A., Granito, A., Gasbarrini, A., Ma, Y. T., Mena, E., Lledó-Navarro, J. L., Presa, J., Weinmann, A., Levy, M. T., Pellicelli, A., Waldschmidt, D. T., Sørensen, H. T., Goyal, L., Ren, M., Saal, H., Okpara, C. E. & Meyer, T. (2026). An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis. Liver Cancer, 1-11. https://doi.org/10.1159/000552115
Carlsen, E. M., Dungu, K. H. S., Lindhard, M. S., Gudiksen, A., Aunsholt, L., Viuff, A.-C., Zacharaissen, G., Greisen, G., Lewis, A., Holm, S. K., Dayani, G., Pedersen, P., Vibede, L. D., Stanchev, H., Jensen, K. V., Fenger-Grøn, J., Lund, S., Agergaard, P., Bender, L. ... Henriksen, T. B. (2026). Individualised duration of antibiotic treatment in culture-negative early-onset sepsis in late-preterm and term-born neonates in Denmark (DURATION): a multicentre, open-label, randomised, controlled, non-inferiority trial. The Lancet Child & Adolecent Health, 10(8), 573-583. https://doi.org/10.1016/S2352-4642(26)00118-5